- RTRX has an average dollar-volume (as measured by average daily share volume multiplied by share price) of $13.4 million.
- RTRX traded 47,501 shares today in the pre-market hours as of 8:32 AM, representing 10.4% of its average daily volume.
EXCLUSIVE OFFER: Get the inside scoop on opportunities in RTRX with the Ticky from Trade-Ideas. See the FREE profile for RTRX NOW at Trade-Ideas More details on RTRX: Retrophin, Inc., a biopharmaceutical company, focuses on the development, acquisition, and commercialization of therapies for the treatment of serious, catastrophic, or rare diseases. RTRX has a PE ratio of 95. Currently there are 2 analysts that rate Retrophin a buy, no analysts rate it a sell, and none rate it a hold. The average volume for Retrophin has been 601,700 shares per day over the past 30 days. Retrophin has a market cap of $930.3 million and is part of the health care sector and drugs industry. The stock has a beta of 0.42 and a short float of 9.9% with 7.07 days to cover. Shares are up 117.4% year-to-date as of the close of trading on Friday. EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.